is semaglutide a biologic new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Unlocking the Genetics of GLP-1
Description
Semaglutide is a medication often prescribed to manage type 2 diabetes

Im excited that Jennifer Gartin made it happen

Primary outcome was percentage weight change from baseline

Purity: 99.0% (validated by Certificate of Analysis)